3 results match your criteria: "Edward Comprehensive Care Center[Affiliation]"
J Breast Cancer
March 2017
Division of Hematology-Oncology, Department of Medicine, Joan C. Edwards School of Medicine at Marshall University/Edward Comprehensive Care Center, Huntington, USA.
Breast cancer is the second leading cause of death among women in North America. Glioblastoma is the most common primary malignant central nervous system tumor in adults. The majority of hereditary breast cancers are associated with deleterious mutations in the and genes.
View Article and Find Full Text PDFCancer Manag Res
February 2017
Division of Hematology/Oncology, Department of Medicine, Joan C. Edwards School of Medicine at Marshall University, Edward Comprehensive Care Center, Huntington, WV, USA.
Hepatocellular cancer (HCC) is a very fatal disease due to limited therapeutic options as well as due to its association with underlying chronic liver disease in the majority of cases. The immune evasion in HCC signifies a major barrier to the delivery of effective immunotherapy. Sorafenib is the only Food and Drug Administration-approved drug available with an overall response rate of 2%-3% and overall survival of 2.
View Article and Find Full Text PDFCase Rep Urol
September 2015
Division of Hematology-Oncology, Department of Medicine, Joan C. Edwards School of Medicine, Marshall University, Edward Comprehensive Care Center, Huntington, WV 25701, USA.
Prostate cancer is the most common cancer in men. Docetaxel is a common chemotherapeutic agent that has proven its efficacy in the treatment of patients with both castration sensitive and resistant metastatic prostate cancer. We report a case of acute respiratory distress syndrome (ARDS) in a patient with metastatic prostate cancer treated with docetaxel (Taxotere).
View Article and Find Full Text PDF